GENOMEPRECISION
Genomeprecision is a molecular diagnostic enterprise integrating R&D, production and sales. It has established “real-time fluorescent quantitative PCR”, “first-generation Sanger sequencing”, “second-generation high-throughput NGS sequencing” and “capillary electrophoresis”. "Fragment Analysis" and "Chemiluminescence CLIA" five molecular diagnostic technology platforms, we will be based on clinical diagnosis and treatment needs to develop molecular diagnostic products based on the above technology platform.
GENOMEPRECISION
Social Links:
Industry:
Biotechnology Health Diagnostics
Founded:
2015-01-01
Status:
Active
Contact:
010-56380026
Total Funding:
14.78 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx Euro PHP
Similar Organizations
Wayra
Wayra is a globally connected and technologically open innovation hub.
Current Employees Featured
Founder
Investors List
Juren Capital
Juren Capital investment in Series B - GenomePrecision
Dynamic Balance Capital
Dynamic Balance Capital investment in Series B - GenomePrecision
Yizhuang Biomedical Mergers and Acquisition Funds
Yizhuang Biomedical Mergers and Acquisition Funds investment in Series B - GenomePrecision
China Growth Capital | CGC
China Growth Capital | CGC investment in Series B - GenomePrecision
Sigma Square Capital
Sigma Square Capital investment in Series B - GenomePrecision
Yueyin Venture Capital
Yueyin Venture Capital investment in Series A - GenomePrecision
Sigma Square Capital
Sigma Square Capital investment in Series A - GenomePrecision
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2016-12-14 | GMINIX | GenomePrecision investment in Series A - GMINIX | 10 M CNY |